Venlafaxine Completed Phase 4 Trials for Spinal Cord Injuries (SCI) / Dysthymic Disorder / Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00592384Project to Improve Symptoms and Mood in People With Spinal Cord Injury
NCT00316160Sexual Functioning Study With Antidepressants
NCT00157547Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
NCT00474708Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
NCT00590863Combining Medications to Enhance Depression Outcomes
NCT00759122Electroencephalography (EEG) Biomarkers of Response in Depression
NCT00401726Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
NCT00627887Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression
NCT00644982A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
NCT01824433Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression
NCT00792168Physiologic Monitoring of Antidepressant Treatment Response